1. Tao, Mingyue, Luo, Jing, Gu, Tong, Luo, Chao, Wang, Qilong. 2021. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma. In Cell death & disease, 12, 845. doi:10.1038/s41419-021-04132-6. https://pubmed.ncbi.nlm.nih.gov/34518524/
2. Wei, Chunhua, Dong, Xiaomin, Lu, Hui, Wu, Gang, Dong, Xiaorong. 2019. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. In Journal of experimental & clinical cancer research : CR, 38, 95. doi:10.1186/s13046-019-1092-4. https://pubmed.ncbi.nlm.nih.gov/30791942/
3. He, Rong-Quan, Li, Jian-Di, Du, Xiu-Fang, Yang, Hong, Chen, Gang. 2021. LPCAT1 overexpression promotes the progression of hepatocellular carcinoma. In Cancer cell international, 21, 442. doi:10.1186/s12935-021-02130-4. https://pubmed.ncbi.nlm.nih.gov/34419067/
4. Liu, Ran, Yin, Chuanzheng, Zhao, Peng, Liu, Gang Logan, Song, Zifang. 2023. Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis. In Biology direct, 18, 67. doi:10.1186/s13062-023-00428-z. https://pubmed.ncbi.nlm.nih.gov/37875967/
5. Li, Lan, Wang, Xiao, Ding, Yanni, Su, Bingjie, Yang, Min. 2022. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. In European journal of medical research, 27, 216. doi:10.1186/s40001-022-00854-1. https://pubmed.ncbi.nlm.nih.gov/36307879/
6. Ji, Weidan, Peng, Zhangxiao, Sun, Bin, Guo, Minggao, Su, Changqing. 2021. LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1. In Frontiers in oncology, 11, 678714. doi:10.3389/fonc.2021.678714. https://pubmed.ncbi.nlm.nih.gov/34178664/
智鼠故事 
